raloxifene hydrochloride has been researched along with cyclic gmp in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Au, CL; Chen, ZY; Cheng, CH; Gollasch, M; Huang, Y; Lau, CW; Leung, FP; Tsang, SY; Wong, CM; Yao, X; Yung, LM | 1 |
Bavbek, M; Belen, D; Beşalti, O; Gürses, L; Oztürk, E; Seçkin, H; Senel, OO; Simşek, S; Yigitkanli, K | 1 |
2 other study(ies) available for raloxifene hydrochloride and cyclic gmp
Article | Year |
---|---|
Raloxifene protects endothelial cell function against oxidative stress.
Topics: Animals; Aorta, Thoracic; Cyclic GMP; Endothelial Cells; Estrogen Antagonists; In Vitro Techniques; Isometric Contraction; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley | 2008 |
Effects of raloxifene on cerebral vasospasm after experimental Subarachnoid Hemorrhage in rabbits.
Topics: Animals; Basilar Artery; Calcium Channels, L-Type; Cerebral Arteries; Cyclic GMP; Disease Models, Animal; Endothelial Cells; Estrogen Receptor alpha; Male; Muscle, Smooth, Vascular; Myosin Light Chains; Rabbits; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Subarachnoid Hemorrhage; Treatment Outcome; Vasodilation; Vasodilator Agents; Vasospasm, Intracranial | 2009 |